What is Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap?

Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value is $2.8B, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$152.1M, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA?

Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA is -$161.7M, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.36, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt?

Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt is -$250.8M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Amylyx Pharmaceuticals, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00DP10YW1

27.20▼ 1.37 (-4.80%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 28.57
Day's Range: 27.06 – 28.46
52-Week Range: 10.83 – 41.14
Volume: 1.1M
Avg Volume: 1.4M

Share Statistics

Shares Outstanding
Employees: 136
Exchange: XNAS
Listed: 2022-01-07

Share count as of July 27, 2026

Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)

What is Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap?: Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$152.1M, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA?: Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA is -$161.7M, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.36, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt?: Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt is -$250.8M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · AMLXAs-filed SEC (XBRL) data